Want to see LEGN full AI Analyst Report?
Legend Biotech (LEGN) Income Statement
Legend Biotech Income Statement
Last quarter (Q2 2026), Legend Biotech's total revenue was $387.50M, an increase of 51.93% from the same quarter last year. In Q2, Legend Biotech's net income was $33.20M. See Legend Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.03B | $ 627.24M | $ 285.14M | $ 117.00M | $ 68.83M | |
| $ 620.80M | $ 392.66M | $ 140.93M | $ 51.64M | $ 68.83M | |
| $ 757.30M | $ 695.90M | $ 580.41M | $ 507.26M | $ 461.11M | |
| Depreciation and Amortization | $ 28.90M | $ 23.36M | $ 20.45M | $ 18.39M | $ 13.92M |
| $ -232.30M | $ -113.16M | $ -477.87M | $ -416.54M | $ -392.38M | |
| $ -136.50M | $ -303.24M | $ -439.49M | $ -455.62M | $ -392.29M | |
| $ -146.10M | $ 145.11M | $ -80.63M | $ 9.90M | $ -14.91M | |
| $ -282.60M | $ -158.13M | $ -520.12M | $ -445.72M | $ -407.20M | |
| $ -296.80M | $ -177.03M | $ -518.25M | $ -446.35M | $ -403.58M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.60 | $ -0.97 | $ -2.94 | $ -2.81 | $ -2.74 |
| Diluted EPS | $ -1.60 | $ -0.97 | $ -2.94 | $ -2.81 | $ -2.74 |
| Weighted Average Shares Outstanding | 184.32M | 182.85M | 176.08M | 159.04M | 140.85M |
| Weighted Average Shares Outstanding (Diluted) | 184.32M | 182.85M | 176.08M | 159.04M | 140.85M |
Currency in USD
